Treatment of narcolepsy is based on the need to regulate life rhythms. Psychostimulants such as modafinil, methylphenidate-immediate release, and pemoline are used to treat hypersomnia. A psychosocial approach is considered the mainstay of treatment for attention-deficit/hyperactivity disorder (ADHD), and medication is used to treat moderate or severe ADHD symptoms. Two of the four drugs approved in Japan for ADHD therapy (osmotic-release oral system methylphenidate and lisdexamfetamine dimesylate) are psychostimulants, which are administered via the ADHD proper distribution management system.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.11477/mf.1416202385 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The effects of psychostimulants in menstruating women with ADHD - A gender health gap in ADHD treatment?
Prog Neuropsychopharmacol Biol Psychiatry
January 2025
Department of Psychiatry and Psychotherapy, University of Leipzig Medical Center, Semmelweisstraße 10, 04103 Leipzig, Germany. Electronic address:
Introduction: Attention-deficit/hyperactivity disorder is a chronic disorder that begins in childhood and often persists into adulthood. There are clinical observations of a cycle-dependent efficacy of psychostimulants in the treatment of ADHD. This relationship appears to be poorly researched.
View Article and Find Full Text PDFTherapeutic targeting of neuroinflammation in methamphetamine use disorder.
Future Med Chem
January 2025
Centre for Drug and Herbal Development, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Methamphetamine (METH) is a highly addictive illicit psychostimulant with a significant annual fatality rate. Emerging studies highlight its role in neuroinflammation and a range of neurological disorders. This review examines the current landscape of potential drug targets for managing neuroinflammation in METH use disorders (MUDs), with a particular focus on the rationale behind targeting Toll-like receptor 4 (TLR4), the NLR family pyrin domain containing 3 (NLRP3) inflammasome, and other promising targets.
View Article and Find Full Text PDFComorbid ADHD and schizophrenia and the use of psychostimulants: a scoping review protocol.
BMJ Open
October 2024
School of Medicine, The University of Manchester, Manchester, UK.
Article Synopsis
- Schizophrenia and ADHD are serious mental health disorders that may share some genetic and symptomatic links, but there’s limited guidance on treating patients with both conditions, specifically regarding psychostimulants.
- This scoping review will systematically gather and analyze existing literature on the effects of psychostimulants for these patients, using a structured framework and screening multiple databases along with grey literature.
- The review aims to fill the gap in high-quality evidence for healthcare providers, helping to inform better treatment decisions and improve outcomes for patients with comorbid schizophrenia and ADHD.
Psychotropic drug use among children and adolescents in the Nordic countries: a systematic review.
Eur Child Adolesc Psychiatry
August 2024
Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.
The Nordic countries have rather homogenous populations and similar health care systems, and one could therefore expect comparable levels of psychopathology and psychotropic drug use. However, recent studies show pronounced variations in psychotropic drug use among children and adolescents from different Nordic countries. Therefore, we aimed to conduct a systematic review of the literature examining the use of psychotropic drugs among children and adolescents in the Nordic countries.
View Article and Find Full Text PDFPsychostimulants and social behaviors.
Front Pharmacol
April 2024
Centro de Investigación Biomédica y Aplicada (CIBAP), Escuela de Medicina, Facultad de Ciencias Médicas, Universidad de Santiago de Chile (USACH), Santiago, Chile.
Mounting evidence from animal models and human studies indicates that psychostimulants can significantly affect social behaviors. This is not surprising considering that the neural circuits underlying the regulation and expression of social behaviors are highly overlapped with those targeted by psychostimulants, which in most cases have strong rewarding and, consequently, addictive properties. In the present work, we provide an overview regarding the effects of illicit and prescription psychostimulants, such as cocaine, amphetamine-type stimulants, methylphenidate or modafinil, upon social behaviors such as social play, maternal behavior, aggression, pair bonding and social cognition and how psychostimulants in both animals and humans alter them.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!